Amakem's Series A Round

Amakem raised a round of funding on September 06, 2011.

Amakem is a kinase platform company focusing on ophthalmology and is developing new treatments for serious eye conditions. The Company's lead candidate, AMA0076, targets glaucoma, a condition which da…

Articles about Amakem's Series A Round: